Literature DB >> 24039638

Comparative effectiveness of dynamic treatment regimes: an application of the parametric g-formula.

Jessica G Young, Lauren E Cain, James M Robins, Eilis J O'Reilly, Miguel A Hernán.   

Abstract

Ideally, randomized trials would be used to compare the long-term effectiveness of dynamic treatment regimes on clinically relevant outcomes. However, because randomized trials are not always feasible or timely, we often must rely on observational data to compare dynamic treatment regimes. An example of a dynamic treatment regime is "start combined antiretroviral therapy (cART) within 6 months of CD4 cell count first dropping below x cells/mm3 or diagnosis of an AIDS-defining illness, whichever happens first" where x can take values between 200 and 500. Recently, Cain et al (2011) used inverse probability (IP) weighting of dynamic marginal structural models to find the x that minimizes 5-year mortality risk under similar dynamic regimes using observational data. Unlike standard methods, IP weighting can appropriately adjust for measured time-varying confounders (e.g., CD4 cell count, viral load) that are affected by prior treatment. Here we describe an alternative method to IP weighting for comparing the effectiveness of dynamic cART regimes: the parametric g-formula. The parametric g-formula naturally handles dynamic regimes and, like IP weighting, can appropriately adjust for measured time-varying confounders. However, estimators based on the parametric g-formula are more efficient than IP weighted estimators. This is often at the expense of more parametric assumptions. Here we describe how to use the parametric g-formula to estimate risk by the end of a user-specified follow-up period under dynamic treatment regimes. We describe an application of this method to answer the "when to start" question using data from the HIV-CAUSAL Collaboration.

Entities:  

Year:  2011        PMID: 24039638      PMCID: PMC3769803          DOI: 10.1007/s12561-011-9040-7

Source DB:  PubMed          Journal:  Stat Biosci        ISSN: 1867-1764


  20 in total

1.  When to start treatment? A systematic approach to the comparison of dynamic regimes using observational data.

Authors:  Lauren E Cain; James M Robins; Emilie Lanoy; Roger Logan; Dominique Costagliola; Miguel A Hernán
Journal:  Int J Biostat       Date:  2010       Impact factor: 0.968

2.  Dynamic regime marginal structural mean models for estimation of optimal dynamic treatment regimes, Part II: proofs of results.

Authors:  Liliana Orellana; Andrea Rotnitzky; James M Robins
Journal:  Int J Biostat       Date:  2010-03-03       Impact factor: 0.968

3.  Diagnosing and responding to violations in the positivity assumption.

Authors:  Maya L Petersen; Kristin E Porter; Susan Gruber; Yue Wang; Mark J van der Laan
Journal:  Stat Methods Med Res       Date:  2010-10-28       Impact factor: 3.021

4.  Doubly robust estimation in missing data and causal inference models.

Authors:  Heejung Bang; James M Robins
Journal:  Biometrics       Date:  2005-12       Impact factor: 2.571

5.  Intervening on risk factors for coronary heart disease: an application of the parametric g-formula.

Authors:  Sarah L Taubman; James M Robins; Murray A Mittleman; Miguel A Hernán
Journal:  Int J Epidemiol       Date:  2009-04-23       Impact factor: 7.196

6.  Marginal Mean Models for Dynamic Regimes.

Authors:  S A Murphy; M J van der Laan; J M Robins
Journal:  J Am Stat Assoc       Date:  2001-12-01       Impact factor: 5.033

7.  A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

Authors:  S M Hammer; K E Squires; M D Hughes; J M Grimes; L M Demeter; J S Currier; J J Eron; J E Feinberg; H H Balfour; L R Deyton; J A Chodakewitz; M A Fischl
Journal:  N Engl J Med       Date:  1997-09-11       Impact factor: 91.245

8.  Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel.

Authors:  Melanie A Thompson; Judith A Aberg; Pedro Cahn; Julio S G Montaner; Giuliano Rizzardini; Amalio Telenti; José M Gatell; Huldrych F Günthard; Scott M Hammer; Martin S Hirsch; Donna M Jacobsen; Peter Reiss; Douglas D Richman; Paul A Volberding; Patrick Yeni; Robert T Schooley
Journal:  JAMA       Date:  2010-07-21       Impact factor: 56.272

9.  The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals.

Authors:  Maile Ray; Roger Logan; Jonathan A C Sterne; Sonia Hernández-Díaz; James M Robins; Caroline Sabin; Loveleen Bansi; Ard van Sighem; Frank de Wolf; Dominique Costagliola; Emilie Lanoy; Heiner C Bucher; Viktor von Wyl; Anna Esteve; Jordi Casbona; Julia del Amo; Santiago Moreno; Amy Justice; Joseph Goulet; Sara Lodi; Andrew Phillips; Rémonie Seng; Laurence Meyer; Santiago Pérez-Hoyos; Patricia García de Olalla; Miguel A Hernán
Journal:  AIDS       Date:  2010-01-02       Impact factor: 4.177

10.  When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study.

Authors:  Lauren E Cain; Roger Logan; James M Robins; Jonathan A C Sterne; Caroline Sabin; Loveleen Bansi; Amy Justice; Joseph Goulet; Ard van Sighem; Frank de Wolf; Heiner C Bucher; Viktor von Wyl; Anna Esteve; Jordi Casabona; Julia del Amo; Santiago Moreno; Remonie Seng; Laurence Meyer; Santiago Perez-Hoyos; Roberto Muga; Sara Lodi; Emilie Lanoy; Dominique Costagliola; Miguel A Hernan
Journal:  Ann Intern Med       Date:  2011-04-19       Impact factor: 25.391

View more
  67 in total

1.  Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.

Authors:  Sara Lodi; Andrew Phillips; Roger Logan; Ashley Olson; Dominique Costagliola; Sophie Abgrall; Ard van Sighem; Peter Reiss; José M Miró; Elena Ferrer; Amy Justice; Neel Gandhi; Heiner C Bucher; Hansjakob Furrer; Santiago Moreno; Susana Monge; Giota Touloumi; Nikos Pantazis; Jonathan Sterne; Jessica G Young; Laurence Meyer; Rémonie Seng; Francois Dabis; Marie-Anne Vandehende; Santiago Pérez-Hoyos; Inma Jarrín; Sophie Jose; Caroline Sabin; Miguel A Hernán
Journal:  Lancet HIV       Date:  2015-07-07       Impact factor: 12.767

2.  A causal framework for classical statistical estimands in failure-time settings with competing events.

Authors:  Jessica G Young; Mats J Stensrud; Eric J Tchetgen Tchetgen; Miguel A Hernán
Journal:  Stat Med       Date:  2020-01-27       Impact factor: 2.373

3.  Effects of intergenerational exposure interventions on adolescent outcomes: An application of inverse probability weighting to longitudinal pre-birth cohort data.

Authors:  Yu-Han Chiu; Sheryl L Rifas-Shiman; Ken Kleinman; Emily Oken; Jessica G Young
Journal:  Paediatr Perinat Epidemiol       Date:  2020-03-12       Impact factor: 3.980

4.  Targeted Maximum Likelihood Estimation for Dynamic and Static Longitudinal Marginal Structural Working Models.

Authors:  Maya Petersen; Joshua Schwab; Susan Gruber; Nello Blaser; Michael Schomaker; Mark van der Laan
Journal:  J Causal Inference       Date:  2014-06-18

5.  Invited commentary: Agent-based models for causal inference—reweighting data and theory in epidemiology.

Authors:  Miguel A Hernán
Journal:  Am J Epidemiol       Date:  2014-12-05       Impact factor: 4.897

6.  Age at Entry Into Care, Timing of Antiretroviral Therapy Initiation, and 10-Year Mortality Among HIV-Seropositive Adults in the United States.

Authors:  Jessie K Edwards; Stephen R Cole; Daniel Westreich; Michael J Mugavero; Joseph J Eron; Richard D Moore; William C Mathews; Peter Hunt; Carolyn Williams
Journal:  Clin Infect Dis       Date:  2015-06-16       Impact factor: 9.079

7.  Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV-positive individuals.

Authors:  Ellen C Caniglia; James M Robins; Lauren E Cain; Caroline Sabin; Roger Logan; Sophie Abgrall; Michael J Mugavero; Sonia Hernández-Díaz; Laurence Meyer; Remonie Seng; Daniel R Drozd; George R Seage Iii; Fabrice Bonnet; Fabien Le Marec; Richard D Moore; Peter Reiss; Ard van Sighem; William C Mathews; Inma Jarrín; Belén Alejos; Steven G Deeks; Roberto Muga; Stephen L Boswell; Elena Ferrer; Joseph J Eron; John Gill; Antonio Pacheco; Beatriz Grinsztejn; Sonia Napravnik; Sophie Jose; Andrew Phillips; Amy Justice; Janet Tate; Heiner C Bucher; Matthias Egger; Hansjakob Furrer; Jose M Miro; Jordi Casabona; Kholoud Porter; Giota Touloumi; Heidi Crane; Dominique Costagliola; Michael Saag; Miguel A Hernán
Journal:  Stat Med       Date:  2019-03-18       Impact factor: 2.373

8.  Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children Ages 1-5 Years: A Causal Modeling Analysis.

Authors:  Michael Schomaker; Mary-Ann Davies; Karen Malateste; Lorna Renner; Shobna Sawry; Sylvie N'Gbeche; Karl-Günter Technau; François Eboua; Frank Tanser; Haby Sygnaté-Sy; Sam Phiri; Madeleine Amorissani-Folquet; Vivian Cox; Fla Koueta; Cleophas Chimbete; Annette Lawson-Evi; Janet Giddy; Clarisse Amani-Bosse; Robin Wood; Matthias Egger; Valeriane Leroy
Journal:  Epidemiology       Date:  2016-03       Impact factor: 4.822

9.  Comparing the Effectiveness of Dynamic Treatment Strategies Using Electronic Health Records: An Application of the Parametric g-Formula to Anemia Management Strategies.

Authors:  Yi Zhang; Jessica G Young; Mae Thamer; Miguel A Hernán
Journal:  Health Serv Res       Date:  2017-05-30       Impact factor: 3.402

10.  Hypothetical midlife interventions in women and risk of type 2 diabetes.

Authors:  Goodarz Danaei; An Pan; Frank B Hu; Miguel A Hernán
Journal:  Epidemiology       Date:  2013-01       Impact factor: 4.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.